Eisler Capital Management Ltd. Acquires 367,645 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Eisler Capital Management Ltd. expanded its stake in Bath & Body Works by acquiring 367,645 shares, increasing its ownership by 348.0% to a total of 473,299 shares valued at approximately $14.35 million.
• Other institutional investors also significantly increased their stakes, with Victory Capital Management acquiring 6,752,274 shares, a 14,732.0% increase, bringing its total to 6,798,108 shares valued at over $206 million.
• Bath & Body Works has declared a quarterly dividend of $0.20 per share, representing a 2.5% yield, with shareholders of record on August 22nd eligible for payment on September 5th.

Eisler Capital Management Ltd. grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 348.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 473,299 shares of the company's stock after acquiring an additional 367,645 shares during the quarter. Eisler Capital Management Ltd. owned 0.22% of Bath & Body Works worth $14,346,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of BBWI. Victory Capital Management Inc. boosted its position in shares of Bath & Body Works by 14,732.0% in the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock valued at $206,119,000 after acquiring an additional 6,752,274 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of Bath & Body Works by 115.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company's stock valued at $111,581,000 after acquiring an additional 1,973,679 shares during the period. Assenagon Asset Management S.A. boosted its position in shares of Bath & Body Works by 3,642.2% in the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock valued at $50,062,000 after acquiring an additional 1,606,988 shares during the period. Interval Partners LP bought a new stake in shares of Bath & Body Works in the fourth quarter valued at approximately $37,992,000. Finally, BNP Paribas Financial Markets bought a new stake in shares of Bath & Body Works in the fourth quarter valued at approximately $36,445,000. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $31.38 on Wednesday. The stock has a fifty day moving average price of $30.49 and a two-hundred day moving average price of $30.90. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87. The firm has a market capitalization of $6.64 billion, a P/E ratio of 8.37, a P/E/G ratio of 1.04 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same period in the prior year, the company posted $0.38 earnings per share. The business's revenue for the quarter was up 2.9% compared to the same quarter last year. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.5%. The ex-dividend date is Friday, August 22nd. Bath & Body Works's dividend payout ratio is currently 21.33%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on BBWI. Morgan Stanley reduced their price objective on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research report on Tuesday, May 6th. UBS Group upped their target price on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a research note on Tuesday, May 20th. JPMorgan Chase & Co. upped their target price on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Wall Street Zen lowered Bath & Body Works from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, Wells Fargo & Company upped their target price on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, May 14th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $42.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.